Literature demonstrates that Snail1 is a key effector in modulating biological process in breast cancer [34, 35], pancreatic cancer [36], lung cancer [37], glioma [38], gastric cancer [39], multiple myeloma [40] and melanoma [41]. This evidence concerns the gene SNAI1 and familial pancreatic carcinoma.